Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PKSI-527

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T35579 Copy Product Info
🥰Excellent
PKSI-527 is a non-covalent, highly selective small molecule inhibitor of plasma kallikrein with an inhibition constant (Ki) of 0.81 µM for plasma kallikrein. PKSI-527 modulates the kallikrein-kinin system by inhibiting bradykinin generation, significantly reduces arthritis severity in a collagen-induced arthritis mouse model, and improves indicators of disseminated intravascular coagulation and organ damage in endotoxin-induced rat models.
PKSI-527
Cas No. 128837-71-8
Pack SizePriceUSA StockGlobal StockQuantity
2 mg$785 days5 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Viscous
Color:Transparent
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
PKSI-527 is a non-covalent, highly selective small molecule inhibitor of plasma kallikrein with an inhibition constant (Ki) of 0.81 µM for plasma kallikrein. PKSI-527 modulates the kallikrein-kinin system by inhibiting bradykinin generation, significantly reduces arthritis severity in a collagen-induced arthritis mouse model, and improves indicators of disseminated intravascular coagulation and organ damage in endotoxin-induced rat models.
In vivo
In vivo, PKSI-527 (300 mg/kg per day) reduces hyperplasia, pannus formation, and infiltration of inflammatory cells in the tarsal joint of mice with collagen-induced arthritis.
Chemical Properties
Molecular Weight473.99
FormulaC25H32ClN3O4
Cas No.128837-71-8
Smiles[C@@H](CC1=CC=CC=C1)(NC(=O)[C@H]2CC[C@H](CN)CC2)C(NC3=CC=C(CC(O)=O)C=C3)=O.Cl
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (168.78 mM), Sonication is recommended.
H2O: 10 mM, Sonication is recommended.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM2.1097 mL10.5487 mL21.0975 mL105.4875 mL
5 mM0.4219 mL2.1097 mL4.2195 mL21.0975 mL
10 mM0.2110 mL1.0549 mL2.1097 mL10.5487 mL
DMSO
1mg5mg10mg50mg
20 mM0.1055 mL0.5274 mL1.0549 mL5.2744 mL
50 mM0.0422 mL0.2110 mL0.4219 mL2.1097 mL
100 mM0.0211 mL0.1055 mL0.2110 mL1.0549 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Keywords

Related Tags: PKSI-527 chemical structure | PKSI-527 in vivo | PKSI-527 formula | PKSI-527 molecular weight